Suchergebnisse - (Person:"Liang, Tingbo")

PubPharm (9)

1

Targeting ubiquitin-specific protease 8 sensitizes anti-programmed death-ligand 1 immunotherapy of pancreatic cancer

enthalten in: Cell death and differentiation | 2023

von Yang, H. | Zhang, X. | Lao, M. | +13

2

Identification of a class of potent USP25/28 inhibitors with broad-spectrum anti-cancer activity

enthalten in: Signal transduction and targeted therapy | 2022

von Peng, J. | Jiang, K. | Sun, X. | +7

3

miR-26b enhances the sensitivity of hepatocellular carcinoma to Doxorubicin via USP9X-dependent degradation of p53 and regulation of autophagy

enthalten in: International journal of biological sciences | 2021

von Chen, E. | Li, E. | Liu, H. | +6

4

Blocking PD-L1 for anti-liver cancer immunity : USP22 represents a critical cotarget

enthalten in: Cellular & molecular immunology | 2020

von Huang, X. | Zhang, X. | Bai, X. | +1

CommentOn: Cancer Immunol Res. 2019 Oct;7(10):1580-1590. - PMID 31399419

5

USP22 Deubiquitinates CD274 to Suppress Anticancer Immunity

enthalten in: Cancer immunology research | 2019

von Huang, X. | Zhang, Q. | Lou, Y. | +9

CommentIn: Cell Mol Immunol. 2020 Jul;17(7):677-679. - PMID 31857703

6

Delivery of miR-212 by chimeric peptide-condensed supramolecular nanoparticles enhances the sensitivity of pancreatic ductal adenocarcinoma to doxorubicin

enthalten in: Biomaterials | 2019

von Chen, W. | Zhou, Y. | Zhi, X. | +9

7

USP9X inhibition improves gemcitabine sensitivity in pancreatic cancer by inhibiting autophagy

enthalten in: Cancer letters | 2018

von Ma, T. | Chen, W. | Zhi, X. | +10

8

Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway

enthalten in: The Journal of biological chemistry | 2018

von Zhu, C. | Ji, X. | Zhang, H. | +9

9

WP1130 increases doxorubicin sensitivity in hepatocellular carcinoma cells through usp9x-dependent p53 degradation

enthalten in: Cancer letters | 2015

von Liu, H. | Chen, W. | Liang, C. | +6

1
[1]